CP and viral infectious disease: In contrast, although phosphorylation-related mutations affecting T306 of SwCM-CP did not cause severe defects in initial viral infections, they either reverted or prompted the emergence of allegedly compensatory second mutations, thus evidencing that altering T306 phosphorylation has a significant fitness cost.